Which definition should be used to determine colchicine resistance among patients with familial Mediterranean fever?

Erden A., Batu E., Sarı A., Sönmez H. E. , Armagan B., Demir S., ...Daha Fazla

Clinical and experimental rheumatology, cilt.36, ss.97-102, 2018 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 36
  • Basım Tarihi: 2018
  • Dergi Adı: Clinical and experimental rheumatology
  • Sayfa Sayıları: ss.97-102


Objective. Colchicine is the main therapy for familial Mediterranean fever (FMF); however, 5-10% of patients are colchicine-resistant. There is no standard and validated definition for colchicine resistance. We aimed to compare the existing definitions for colchicine resistance in both adult and paediatric FMF patients to find out the best definition to determine colchicine-resistant patients.